NCT05695027View on ClinicalTrials.gov

Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

January 31, 2028

Conditions
Primary Open Angle Glaucoma
Interventions
DRUG

Dietary supplements - Nicotinamide and Pyruvate

Nutritional supplements

DRUG

Placebo

Placebo

Trial Locations (3)

10022

RECRUITING

ColumbiaDoctors Ophthalmology - 880 Third Avenue, New York

10032

RECRUITING

Columbia University Irving Medical Center - 622 W 168th St, New York

94303

RECRUITING

Stanford University Department of Ophthalmology, Palo Alto

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Columbia University

OTHER